117 related articles for article (PubMed ID: 12238921)
1. Angiotensin II vs its type I antagonists: conformational requirements for receptor binding assessed from NMR spectroscopic and receptor docking experiments.
Wilkes BC; Masaro L; Schiller PW; Carpenter KA
J Med Chem; 2002 Sep; 45(20):4410-8. PubMed ID: 12238921
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of prolactin secretion from rat pituitary by luteinizing hormone-releasing hormone: evidence against mediation by angiotensin II acting through a (Sar1-Ala8)-angiotensin II-sensitive receptor.
Robberecht W; Andries M; Denef C
Neuroendocrinology; 1992 Aug; 56(2):185-94. PubMed ID: 1407372
[TBL] [Abstract][Full Text] [Related]
3. Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.
Hsieh KH; LaHann TR; Speth RC
J Med Chem; 1989 Apr; 32(4):898-903. PubMed ID: 2704034
[TBL] [Abstract][Full Text] [Related]
4. Lack of specific inhibition of angiotensin II in eels by angiotensin antagonists.
Nishimura H; Norton VM; Bumpus FM
Am J Physiol; 1978 Jul; 235(1):H95-103. PubMed ID: 677333
[TBL] [Abstract][Full Text] [Related]
5. Stimulating effects of angiotensin I, angiotensin II and des-Asp1-angiotensin II on steroid production in vitro and its inhibition by Sar1-Ala8-angiotensin II.
Hepp R; Grillet C; Peytremann A; Vallotton MB
Prog Biochem Pharmacol; 1976; 12():41-8. PubMed ID: 1019169
[TBL] [Abstract][Full Text] [Related]
6. Proposals for the angiotensin II receptor-bound conformation by comparative computer modeling of AII and cyclic analogs.
Joseph MP; Maigret B; Scheraga HA
Int J Pept Protein Res; 1995 Dec; 46(6):514-26. PubMed ID: 8748712
[TBL] [Abstract][Full Text] [Related]
7. An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of nuclear magnetic resonance spectroscopy and theoretical calculations.
Mavromoustakos T; Kolocouris A; Zervou M; Roumelioti P; Matsoukas J; Weisemann R
J Med Chem; 1999 May; 42(10):1714-22. PubMed ID: 10346924
[TBL] [Abstract][Full Text] [Related]
8. Conformational analysis of two cyclic analogs of angiotensin: implications for the biologically active conformation.
Nikiforovich GV; Kao JL; Plucinska K; Zhang WJ; Marshall GR
Biochemistry; 1994 Mar; 33(12):3591-8. PubMed ID: 8142357
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of angiotensin II analogues containing a Val-His replacement, Val psi[CH(CONH2)NH]His.
Mohan R; Chou YL; Bihovsky R; Lumma WC; Erhardt PW; Shaw KJ
J Med Chem; 1991 Aug; 34(8):2402-10. PubMed ID: 1875337
[TBL] [Abstract][Full Text] [Related]
10. An investigation of angiotensin II agonist and antagonist analogues with 5,5-dimethylthiazolidine-4-carboxylic acid and other constrained amino acids.
Samanen J; Cash T; Narindray D; Brandeis E; Adams W; Weideman H; Yellin T; Regoli D
J Med Chem; 1991 Oct; 34(10):3036-43. PubMed ID: 1920354
[TBL] [Abstract][Full Text] [Related]
11. AT1 receptor characteristics of angiotensin analogue binding in human synovium.
Walsh DA; Suzuki T; Knock GA; Blake DR; Polak JM; Wharton J
Br J Pharmacol; 1994 Jun; 112(2):435-42. PubMed ID: 8075862
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II binding sites in frog kidney and adrenal.
Kloas W; Hanke W
Peptides; 1992; 13(2):349-54. PubMed ID: 1409013
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor-mediated calcium influx in bovine adrenal glomerulosa cells.
Ambroz C; Catt KJ
Endocrinology; 1992 Jul; 131(1):408-14. PubMed ID: 1377126
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin receptors in an Australian marsupial, the brushtail possum Trichosurus vulpecula.
Sernia C; Lello P; Thomas WG
Gen Comp Endocrinol; 1990 Jan; 77(1):116-26. PubMed ID: 2295416
[TBL] [Abstract][Full Text] [Related]
15. The effect of angiotensin II upon electrogenic ion transport in rat intestinal epithelia.
Cox HM; Cuthbert AW; Munday KA
Br J Pharmacol; 1987 Feb; 90(2):393-401. PubMed ID: 3828657
[TBL] [Abstract][Full Text] [Related]
16. Cardiac effects of angiotensin antagonists in normotensive rats.
Sen S; Tarazi RC; Bumpus FM
Clin Sci (Lond); 1979 May; 56(5):439-43. PubMed ID: 157829
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II is retained in gonadotrophs of pituitary cell aggregates cultured in serum-free medium but does not mimic the effects of exogenous angiotensins and luteinizing-hormone-releasing hormone on growth hormone release.
Robberecht W; Andries M; Denef C
Neuroendocrinology; 1992 Oct; 56(4):550-60. PubMed ID: 1475013
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists.
Bovy PR; O'Neal JM; Olins GM; Patton DR; McMahon EG; Palomo M; Koepke JP; Salles KS; Trapani AJ; Smits GJ
J Med Chem; 1990 May; 33(5):1477-82. PubMed ID: 2329570
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
Balla T; Baukal AJ; Eng S; Catt KJ
Mol Pharmacol; 1991 Sep; 40(3):401-6. PubMed ID: 1654513
[TBL] [Abstract][Full Text] [Related]
20. On the structural basis of the hypertensive properties of angiotensin II: a solved mystery or a controversial issue?
Tzakos AG; Gerothanassis IP; Troganis AN
Curr Top Med Chem; 2004; 4(4):431-44. PubMed ID: 14965310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
